Published April 8, 2014
| Version v1
Journal article
Critical Role of Aberrant Angiogenesis in the Development of Tumor Hypoxia and Associated Radioresistance
- 1. Clinical Cooperation Group "Innate Immunity in Tumor Biology", Helmholtz Zentrum München (HMGU), Ingolstädter Landstraße 1, 85764 Neuherberg (Germany)
- 2. Department of Radiotherapy and Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Straße 22, 81675 Munich (Germany)
- 3. multimmune GmbH, Munich, Ismaningerstr. 22, 81675 Munich (Germany)
Description
Newly formed microvessels in most solid tumors show an abnormal morphology and thus do not fulfil the metabolic demands of the growing tumor mass. Due to the chaotic and heterogeneous tumor microcirculation, a hostile tumor microenvironment develops, that is characterized inter alia by local hypoxia, which in turn can stimulate the HIF-system. The latter can lead to tumor progression and may be involved in hypoxia-mediated radioresistance of tumor cells. Herein, cellular and molecular mechanisms in tumor angiogenesis are discussed that, among others, might impact hypoxia-related radioresistance
Availability note (English)
Available from http://dx.doi.org/10.3390/cancers6020813; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074805Additional details
Identifiers
Publishing Information
- Journal Title
- Cancers (Basel)
- Journal Volume
- 6
- Journal Issue
- 2
- Journal Page Range
- p. 813-828
- ISSN
- 2072-6694
INIS
- Country of Publication
- Switzerland
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 47006736
- Subject category
- S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS; S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ANGIOGENESIS; NEOPLASMS; RADIOSENSITIVITY; TUMOR CELLS
- Descriptors DEC
- ANIMAL CELLS; DISEASES; SENSITIVITY
Optional Information
- Copyright
- Copyright (c) 2014 by the authors
- Notes
- PMCID: PMC4074805; PMID: 24717239; PUBLISHER-ID: cancers-06-00813; OAI: oai:pubmedcentral.nih.gov:4074805; licensee MDPI, Basel, Switzerland.; This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).